Maarten O. van Aken

Treatment With the Radiolabeled Somatostatin Analog [ ¹⁷⁷ Lu-DOTA ⁰ ,Tyr ³ ]Octreotate: Toxicity, Efficacy, and Survival

Dik J. Kwekkeboom, Wouter W. de Herder, Boen L.R. Kam et al. · Journal of Clinical Oncology · 2008 · 1.4K citations · Full text

Medicine, Nuclear Medicine, Oncology +17

The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5

Leo J. Hofland, Joost van der Hoek, Richard A. Feelders et al. · European Journal of Endocrinology · 2005 · 274 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

Quality of Life in Patients after Long-Term Biochemical Cure of Cushing’s Disease

Maarten O. van Aken, Alberto M. Pereira, Nienke R. Biermasz et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 251 citations · Full text

Medicine, Endocrinology, Internal Medicine +17

Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire

Susan M. Webb, María José Barahona, Annamaria Colao et al. · European Journal of Endocrinology · 2008 · 230 citations · Full text

Medicine, Endocrinology, Health Sciences +17

Mortality in Patients Treated for Cushing’s Disease Is Increased, Compared with Patients Treated for Nonfunctioning Pituitary Macroadenoma

Olaf M. Dekkers, Nienke R. Biermasz, Alberto M. Pereira et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 225 citations · Full text

Medicine, Endocrinology, Surgery +17